Imaging has shown significant reduction in tumour volume from an estimated 28 ml at diagnosis to 1 ml in 2019 (Fig. 2); latest prolactin level is 5892 mU/l, and he has a minor ongoing visual field impairment. This evidence concerns the gene PRL and neoplasm.